{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:04:16Z","timestamp":1779296656853,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10096-020-03830-x","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:03:43Z","timestamp":1594202623000},"page":"1123-1127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modeling the risk of fluoroquinolone resistance in non-severe community-onset pyelonephritis"],"prefix":"10.1007","volume":"39","author":[{"given":"Antoine","family":"Leforestier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Anne","family":"Vibet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Gentet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Javaudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quentin","family":"Le Bastard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Montassier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1927-228X","authenticated-orcid":false,"given":"Eric","family":"Batard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"3830_CR1","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103\u2013e120. https:\/\/doi.org\/10.1093\/cid\/ciq257","journal-title":"Clin Infect Dis"},{"key":"3830_CR2","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/jac\/dkz274","volume":"74","author":"A Quaegebeur","year":"2019","unstructured":"Quaegebeur A, Brunard L, Javaudin F, Vibet M-A, Bemer P, Le Bastard Q et al (2019) Trends and prediction of antimicrobial susceptibility in urinary bacteria isolated in European emergency departments: the EuroUTI 2010\u20132016 study. J Antimicrob Chemother 74:3069\u20133076. https:\/\/doi.org\/10.1093\/jac\/dkz274","journal-title":"J Antimicrob Chemother"},{"key":"3830_CR3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41591-019-0503-6","volume":"25","author":"I Yelin","year":"2019","unstructured":"Yelin I, Snitser O, Novich G, Katz R, Tal O, Parizade M et al (2019) Personal clinical history predicts antibiotic resistance of urinary tract infections. Nat Med 25:1143\u20131152. https:\/\/doi.org\/10.1038\/s41591-019-0503-6","journal-title":"Nat Med"},{"key":"3830_CR4","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y (2014) Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J 35:1925\u20131931. https:\/\/doi.org\/10.1093\/eurheartj\/ehu207","journal-title":"Eur Heart J"},{"key":"3830_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MEJ.0000000000000331","volume":"24","author":"E Batard","year":"2017","unstructured":"Batard E, Vibet M-A, Lemarchand C, Navas D, Lepelletier D, Potel G et al (2017) Use of broad-spectrum antibiotics in French EDs: different trends for third-generation cephalosporins and fluoroquinolones. Eur J Emerg Med 24:189\u2013195. https:\/\/doi.org\/10.1097\/MEJ.0000000000000331","journal-title":"Eur J Emerg Med"},{"key":"3830_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s15010-015-0793-7","volume":"43","author":"E Batard","year":"2015","unstructured":"Batard E, Lecadet N, Goffinet N, Hardouin JB, Lepelletier D, Potel G et al (2015) High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia. Infection 43:681\u2013689. https:\/\/doi.org\/10.1007\/s15010-015-0793-7","journal-title":"Infection"},{"key":"3830_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10096-018-3339-y","volume":"37","author":"S Gennai","year":"2018","unstructured":"Gennai S, Ortiz S, Boussat B, Fran\u00e7ois P, Pavese P (2018) Evaluation of ceftriaxone prescriptions in the emergency department of a university hospital: an urgent need for improvement and alternative therapy. Eur J Clin Microbiol Infect Dis 37:2063\u20132068. https:\/\/doi.org\/10.1007\/s10096-018-3339-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3830_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12879-019-4191-0","volume":"19","author":"B Kim","year":"2019","unstructured":"Kim B, Myung R, Lee M-J, Kim J, Pai H (2019) Trend of antibiotics usage for acute pyelonephritis in Korea based on national health insurance data 2010\u20132014. BMC Infect Dis 19:554. https:\/\/doi.org\/10.1186\/s12879-019-4191-0","journal-title":"BMC Infect Dis"},{"key":"3830_CR9","doi-asserted-by":"publisher","unstructured":"Soucy J, Schmidt AM, Quach C, Buckeridge DL (2019) Fluoroquinolone use and seasonal patterns of ciprofloxacin resistance in community-acquired urinary Escherichia coli in a large urban center. Am J Epidemiol. https:\/\/doi.org\/10.1093\/aje\/kwz239","DOI":"10.1093\/aje\/kwz239"},{"key":"3830_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/cis509","volume":"55","author":"L Sun","year":"2012","unstructured":"Sun L, Klein EY, Laxminarayan R (2012) Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis 55:687\u2013694. https:\/\/doi.org\/10.1093\/cid\/cis509","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-020-03830-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:21:22Z","timestamp":1611879682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-020-03830-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["3830"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03830-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"21 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"According to the French law, patients received written information and gave oral consent to participate. All procedures were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}